ITCI
Baird Financial Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-64,474
| Closed | -$5.38M | – | 1847 |
|
|
2024
Q4 | $5.38M | Buy |
64,474
+16,711
| +35% | +$1.4M | 0.01% | 663 |
|
|
2024
Q3 | $3.49M | Buy |
47,763
+11,537
| +32% | +$844K | 0.01% | 796 |
|
|
2024
Q2 | $2.48M | Buy |
+36,226
| New | +$2.48M | 0.01% | 895 |
|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$257K | – | 1587 |
|
|
2020
Q2 | $257K | Buy |
+10,000
| New | +$257K | ﹤0.01% | 1351 |
|